Romiplostim N01

romiplostim · Amgen

Drug timelines are a Plus or Pro feature.

10 regulatory and trial events tracked for Romiplostim N01, covering 2024-06-04 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Romiplostim N01 in the Treatment of Refractory Chemoradiotherapy-induced AA [Phase 2]